pharmaceutical investing Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
medical device investing AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
pharmaceutical investing Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554
FPX Nickel Announces Funding Contribution from Natural Resources Canada to Advance the Baptiste Nickel Project
SAGA Metals Expands Radar Ti-V-Fe Project Vision with Preliminary Metallurgical Insights and Major Exploration Milestones
Homerun Resources Inc. Announces Updated Offtake Agreement with Brasil Fotovoltaico for the Supply of High-Quality Solar Glass
